Nevertheless, if ODC1 deficiency is a frequent phenomenon in urothelial carcinogenesis, later on in the course of tumor progression, tumor cells need to adapt to it, counter or overcome it by still unknown mechanisms, which may include the impediment of checkpoints characteristic of advanced bladder cancers. The gene discussed is ODC1; the disease is urinary bladder carcinoma.